Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
LIMES Schlosskliniken AG (LIK.DE)
Cologne, DE
LIMES Schlosskliniken AG oversees private healthcare facilities specializing in psychiatric, psychotherapeutic, and psychosomatic treatments. The organization primarily concentrates on addressing conditions arising from stress, alongside a variety of psychological and emotional disorders such as depression, severe burnout, mood disorders, and trauma. Headquartered in Cologne, Germany, LIMES Schlosskliniken AG operates as a subsidiary of GMF Capital GmbH.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +4.84% | +1.96% | +6.12% | +1.96% | +54.76% | +44.44% | +57.58% | +51.16% | +316.00% | +408.51% | +408.51% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 2 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Medical - Care Facilities: +10.2%+33.5% ★ Q4'25: +16.4% (vs Q4'23)
-
EPS growth Medical - Care Facilities: +19.2%+80.1% ★ Q4'25: -4.2% (vs Q4'23)
-
FCF margin FCF growth · Medical - Care Facilities: +32.0%+9.9% Q4'25: +5.9% (vs Q4'23)
-
EBIT margin Medical - Care Facilities: +11.3%+18.6% ★ Q4'25: +16.3% (vs Q4'23)
-
ROIC Medical - Care Facilities: +6.8%+26.5% ★ Q4'25: +47.9% (vs Q4'23)
-
Share dilution Medical - Care Facilities: +0.0%+1.6% Q4'25: +1.6% (vs Q4'23)
-
Debt / EBITDA Net debt/EBITDA · Medical - Care Facilities: 0.99×0.84× ★ Q4'25: 0.41× (vs Q4'23)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 2 Rev. Ana. 1 EPS Ana. |
Dec 2027 2 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|
| Revenue |
8.18M
est: 9.66M (-15.3%)
|
11.02M
est: 12.45M (-11.5%)
|
23.43M
est: 16.08M (+45.8%)
|
28.81M
est: 20.43M (+41.0%)
|
37.17M
est: 41.78M (-11.0%)
|
37.45M
est: 41.87M (-10.5%)
|
50.00M
est: 53.10M (-5.8%)
|
66.40M
65.50M – 67.30M
+25.0% YoY
|
75.67M
72.05M – 79.30M
+14.0% YoY
|
| EBITDA |
263.3K
est: 1.99M (-86.7%)
|
837.7K
est: 2.51M (-66.6%)
|
6.02M
est: 3.24M (+85.7%)
|
8.65M
est: -4.27M (+302.6%)
|
7.67M
est: 10.09M (-24.0%)
|
7.05M
est: 10.11M (-30.3%)
|
12.79M
est: 12.82M (-0.2%)
|
16.04M
15.82M – 16.25M
+25.0% YoY
|
18.28M
17.40M – 19.15M
+14.0% YoY
|
| EBIT |
-539.6K
est: 1.18M (-145.6%)
|
-426.9K
est: 1.50M (-128.5%)
|
4.53M
est: 1.93M (+134.6%)
|
6.00M
est: -2.00M (+400.5%)
|
5.03M
est: 7.00M (-28.2%)
|
4.29M
est: 7.01M (-38.8%)
|
9.31M
est: 8.89M (+4.7%)
|
11.12M
10.97M – 11.27M
+25.0% YoY
|
12.67M
12.07M – 13.28M
+14.0% YoY
|
| Net Income |
-825.0K
est: -553.8K (-49.0%)
|
-694.4K
est: 113.1K (-714.1%)
|
3.94M
est: 383.9K (+927.4%)
|
4.20M
est: -3.13M (+234.1%)
|
3.40M
|
3.11M
est: 4.60M (-32.3%)
|
5.69M
est: 7.09M (-19.6%)
|
11.68M
11.20M – 12.16M
+64.8% YoY
|
15.68M
15.03M – 16.33M
+34.2% YoY
|
| SGA |
2.76M
est: 1.98M (+39.4%)
|
3.40M
est: 2.50M (+35.9%)
|
5.64M
est: 3.23M (+74.9%)
|
6.06M
est: 11.72M (-48.3%)
|
6.82M
est: 8.26M (-17.5%)
|
3.01M
est: 8.28M (-63.6%)
|
13.70M
est: 10.50M (+30.4%)
|
13.13M
12.96M – 13.31M
+25.0% YoY
|
14.97M
14.25M – 15.69M
+14.0% YoY
|
| EPS |
-2.81
est: -1.89 (-48.8%)
|
-2.37
est: 0.38 (-717.5%)
|
13.45
est: 1.30 (+932.3%)
|
14.34
est: 2.06 (+596.6%)
|
11.58
|
10.61
est: 15.68 (-32.3%)
|
19.11
est: 23.78 (-19.6%)
|
39.20
37.58 – 40.82
+64.8% YoY
|
52.62
50.44 – 54.80
+34.2% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-28 | B+ | 3/5 | 3/5 | 5/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-05-27 | B+ | 3/5 | 3/5 | 5/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-05-26 | B+ | 3/5 | 3/5 | 5/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-05-25 | B+ | 3/5 | 3/5 | 5/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-05-22 | B+ | 3/5 | 3/5 | 5/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-05-21 | B+ | 3/5 | 3/5 | 5/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-05-20 | B+ | 3/5 | 3/5 | 5/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-05-19 | B+ | 3/5 | 3/5 | 5/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-05-18 | B+ | 3/5 | 3/5 | 5/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-05-15 | B+ | 3/5 | 3/5 | 5/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-05-14 | B+ | 3/5 | 3/5 | 5/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-05-13 | B+ | 3/5 | 3/5 | 5/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-05-12 | B+ | 3/5 | 3/5 | 5/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-05-11 | B+ | 3/5 | 3/5 | 5/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-05-08 | B+ | 3/5 | 3/5 | 5/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-05-07 | B+ | 3/5 | 3/5 | 5/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-05-06 | B+ | 3/5 | 3/5 | 5/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-05-05 | B+ | 3/5 | 3/5 | 5/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-05-04 | B+ | 3/5 | 3/5 | 5/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-30 | B+ | 3/5 | 3/5 | 5/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-29 | B+ | 3/5 | 3/5 | 5/5 | 5/5 | 1/5 | 3/5 | 2/5 |
| 2026-04-28 | B+ | 3/5 | 3/5 | 5/5 | 5/5 | 1/5 | 3/5 | 2/5 |
| 2026-04-27 | B+ | 3/5 | 3/5 | 5/5 | 5/5 | 1/5 | 3/5 | 2/5 |
| 2026-04-24 | B+ | 3/5 | 3/5 | 5/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-23 | B+ | 3/5 | 3/5 | 5/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-22 | B+ | 3/5 | 3/5 | 5/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-21 | B+ | 3/5 | 3/5 | 5/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-20 | B+ | 3/5 | 3/5 | 5/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-17 | B+ | 3/5 | 3/5 | 5/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-16 | B+ | 3/5 | 3/5 | 5/5 | 5/5 | 1/5 | 2/5 | 2/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Gert Michael Frank | CEO, Member of the Management Board & Director | — | — |
| Kjell Brolund-Spaether | Chief Medical Officer & Member of the Management Board | — | — |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for LIK.DE
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
